Α gel-containing composition and use thereof
The α-gel composition, containing biosurfactants and higher alcohols, addresses the encapsulation of water and oil, providing stability and usability in cosmetics and pharmaceuticals by enhancing emulsification and thickening.
Patent Information
- Application Number
- JP2023223509
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-15
- Filing Date
- 2023-12-28
- Publication Date
- 2024-11-27
AI Technical Summary
Conventional gel-like compositions do not effectively encapsulate both water and oil, lacking stability and usability in cosmetics and pharmaceutical products.
An α-gel-containing composition is developed, comprising a biosurfactant, preferably an anionic biosurfactant like succinoyl trehalose lipid, and a higher alcohol, with specific ratios and pH conditions, optionally including an oil agent, polyhydric alcohol, and thickener, to enhance stability and usability.
The α-gel composition exhibits excellent stability and a good feel when used in cosmetics or pharmaceutical products, with improved emulsification and thickening properties.
Smart Images

Figure 2024164792000001 
Figure 2024164792000002 
Figure 2024164792000003
Abstract
Description
[Technical field]
[0001] The present invention relates to an α-gel-containing composition and its use, in particular to an α-gel-containing composition containing a biosurfactant and its use. [Background technology]
[0002] Biosurfactants, functional substances produced by microorganisms, are amphipathic substances that have hydrophobic and hydrophilic parts. Biosurfactants have attracted attention as natural surfactants that exhibit excellent biodegradability, and because they also exhibit high moisturizing and emulsifying effects, their use as additives in cosmetics, medicines, foods, etc. has been considered.
[0003] For example, Patent Document 1 discloses that, for the purpose of providing an aqueous gel composition containing a biosurfactant, an aqueous gel composition was prepared by mixing a salt of succinoyl trehalose lipid, which is a glycolipid-type biosurfactant, with an aqueous component.
[0004] Furthermore, Patent Document 2 discloses that, for the purpose of providing an oily gel composition containing a biosurfactant, an oily gel composition containing a biosurfactant having a glycolipid structure and containing either water or a polyhydric alcohol, and an oily component has been prepared. [Prior art documents] [Patent documents]
[0005] [Patent Document 1] JP 2009-67686 A [Patent Document 2] JP 2009-79030 A Summary of the Invention [Problem to be solved by the invention]
[0006] While conventional gel compositions as described above exist, in recent years, a form called α-gel, which can encapsulate both water and oil, has been attracting attention.
[0007] Alpha gel, also known as alpha-type hydrated crystals, is generally formed when a compound having hydrophilic and lipophilic groups, such as a surfactant, is used as a lamellar gel-forming composition. It is a gel in which a large amount of water is retained between the layers of the hexagonal alpha-type structure, and is expected to have high thickening, water retention, and barrier effects.
[0008] One aspect of the present invention aims to provide an α-gel-containing composition that contains a biosurfactant, which has excellent stability and excellent usability when used in cosmetics or medicinal (quasi-drug) products. [Means for solving the problem]
[0009] In order to solve the above problems, one embodiment of the present invention includes the following configuration. [1] An α-gel-containing composition comprising a biosurfactant and a higher alcohol. [2] The α-gel-containing composition described in [1], wherein the biosurfactant includes an anionic biosurfactant. [3] The α-gel-containing composition described in [1] or [2], wherein the biosurfactant includes a biosurfactant having a glycolipid structure. [4] The α-gel-containing composition according to any one of [1] to [3], wherein the biosurfactant having a glycolipid structure is succinoyl trehalose lipid. [5] The α-gel-containing composition according to any one of [1] to [4], wherein the biosurfactant is contained in an amount of 0.001% by mass or more relative to the total mass of the α-gel-containing composition. [6] The α-gel-containing composition described in any one of [1] to [5], wherein the higher alcohol includes at least one of a higher alcohol having 16 carbon atoms and a higher alcohol having 18 carbon atoms. [7] The α-gel-containing composition described in any of [1] to [6], wherein the ratio of the content of the biosurfactant to the content of the higher alcohol, in terms of mass ratio, is greater than 0 and less than or equal to 0.500. [8] The α-gel-containing composition according to any one of [1] to [7], having a pH of 5.0 or higher. [9] The α-gel-containing composition described in any of [1] to [8], further comprising at least one selected from the group consisting of oils, polyhydric alcohols, and thickeners.
[10] The α-gel-containing composition described in [9], which contains an oily agent, and the ratio of the content of the oily agent to the content of the higher alcohol is, in mass ratio, greater than 0 and less than 35.0.
[11] A cosmetic or medicinal (quasi-drug) product comprising the α-gel-containing composition according to any one of [1] to
[10] . Effect of the Invention
[0010] According to one aspect of the present invention, it is possible to provide an α-gel-containing composition that has excellent stability and provides an excellent feeling when used in cosmetics or medicinal (quasi-drug) products. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0011] An embodiment of the present invention will be described below, but the present invention is not limited thereto. The present invention is not limited to each of the configurations described below, and various modifications are possible within the scope of the claims. The technical scope of the present invention also includes embodiments obtained by appropriately combining the technical means disclosed in different embodiments. In this specification, unless otherwise specified, "A to B" representing a numerical range means "A or more, B or less."
[0012] [1. α-gel-containing composition] The α-gel-containing composition according to one embodiment of the present invention contains a biosurfactant and a higher alcohol.
[0013] As used herein, the term "biosurfactant" is a general term for substances that are produced (biosynthesized) by living organisms (eg, microorganisms) and have surface activity and / or emulsifying ability.
[0014] The α-gel-containing composition of one embodiment of the present invention contains a biosurfactant produced by an organism (e.g., a microorganism) as a substance with surface activity and / or emulsification ability, thereby providing the effects of excellent stability and excellent usability when used in cosmetics or medicinal (quasi-drug) products.
[0015] Alpha gel refers to a gel containing alpha-type hydrated crystals in which an amphiphilic substance having a hydrophilic group and a lipophilic group, such as a surfactant, forms an association of bilayer membranes stacked in a lamellar shape, and water is held between the hydrophilic groups. Alpha gel also includes gels in which water is held between the hydrophilic groups of the bilayer membrane and a large amount of water is held in the hydrophilic part of the association. The amphiphilic substance is arranged in a hexagonal shape in the bilayer membrane.
[0016] When α-gel is formed, repeating peaks indicating the layered structure of a bilayer membrane and one sharp peak indicating hexagonal packing are observed in the small-angle X-ray scattering region in X-ray diffraction. The formation of α-gel in a composition can be confirmed by X-ray diffraction patterns. Specifically, as shown in the examples described later, when a sharp peak is present between 21° and 22° in the wide-angle region, it can be determined that the composition is an α-gel-containing composition. The α-gel-containing composition of the present disclosure preferably has at least one peak in the vicinity of 20° to 24° of the diffraction angle (2θ) by X-ray diffraction (wide angle), and more preferably has one peak in the vicinity of 21° to 22°.
[0017] (Biosurfactant) In one embodiment of the present invention, the biosurfactant is not particularly limited as long as it is a substance that is produced (biosynthesized) by an organism (e.g., a microorganism) and has surface activity and / or emulsification ability, and may include at least one selected from anionic biosurfactants, cationic biosurfactants, amphoteric biosurfactants, and nonionic biosurfactants.
[0018] Among them, the biosurfactant preferably includes an anionic biosurfactant. In this specification, the anionic biosurfactant is intended to mean an anionic biosurfactant. In this specification, the term "anionic" is intended to mean that the hydrophilic group is ionized in water to become negatively charged. In order for a compound to have an anionic property, it is necessary to have an acidic functional group such as a carboxyl group, a sulfonic acid group, or a sulfate ester group. Therefore, the anionic biosurfactant can be said to be a biosurfactant having an acidic functional group.
[0019] The anionic biosurfactant is not particularly limited as long as it is an anionic substance produced by a living organism and has surface activity and / or emulsification ability, and examples thereof include biosurfactants having a glycolipid structure, biosurfactants having an amino acid structure, biosurfactants having an organic acid structure, and biosurfactants having a polymer structure. The anionic biosurfactant may contain only one of the various anionic biosurfactants described above, or may contain two or more of them.
[0020] In one embodiment of the present invention, examples of the biosurfactant having a glycolipid structure that the anionic biosurfactant may contain include succinoyltrehalose lipid (hereinafter sometimes referred to as STL) and sophorolipid.
[0021] In one embodiment of the present invention, the anionic biosurfactant may contain succinoyl trehalose lipid, which can be obtained by aerobically culturing Rhodococcus erythropolis SD-74 strain in a medium containing a carbon source such as fatty acid or vegetable oil, or by aerobically culturing Rhodococcus sp. TB-42 strain in a medium containing a carbon source such as unsaturated hydrocarbons or halogenated hydrocarbons. The Rhodococcus erythropolis SD-74 strain has been deposited at the National Institute of Technology and Evaluation, Patent Microorganisms Depositary Center under "Deposit Number: NITE P-03788 (Deposit Date: December 1, 2022)".
[0022] Succinoyltrehalose lipid obtained by culturing a microorganism in a medium containing a carbon source is a glycolipid in which the sugar portion is trehalose and 1 to 2 moles each of succinic acid and fatty acid are ester-linked per mole of trehalose. The fatty acid portion of this glycolipid is derived from the carbon source, which is the culture substrate, and different fatty acids can be bound by changing the composition of the carbon source. In particular, from the viewpoint of emulsifying ability in a weakly acidic range, the fatty acids each independently contain preferably 5 to 30, more preferably 8 to 25, even more preferably 10 to 22, and particularly preferably 12 to 20 aliphatic hydrocarbon groups. The aliphatic hydrocarbon groups may be alkyl groups.
[0023] In one embodiment of the present invention, the succinoyl trehalose lipid that the anionic biosurfactant may contain may be, for example, a compound having a structure represented by the following general formula 1:
[0024] [ka]
[0025] In the above general formula 1, the substituents R1 and R2 are aliphatic hydrocarbon groups.
[0026] In one embodiment of the present invention, the aliphatic hydrocarbon groups which are the substituents R1 and R2 in general formula 1 may each independently be linear or branched, and from the viewpoint of assimilation of the raw material carbon source, linear is preferred.
[0027] In one embodiment of the present invention, the aliphatic hydrocarbon groups which are the substituents R1 and R2 in general formula 1 may each independently be an alkyl group having 5 to 30 carbon atoms. The alkyl group preferably has 8 or more carbon atoms, more preferably has 10 or more carbon atoms, and even more preferably has 12 or more carbon atoms. The alkyl group preferably has 25 or less carbon atoms, more preferably has 22 or less carbon atoms, and even more preferably has 20 or less carbon atoms.
[0028] The succinoyl trehalose lipid having the structure of general formula 1 can be obtained, for example, by aerobically culturing Rhodococcus erythropolis SD-74 strain in a medium containing a carbon source such as fatty acid or vegetable oil, or by aerobically culturing Rhodococcus sp. TB-42 strain in a medium containing a carbon source such as unsaturated hydrocarbon or halogenated hydrocarbon.
[0029] When a succinoyl trehalose lipid is produced by culturing a microorganism in a medium containing a carbon source containing an alkylene oxide, the resulting succinoyl trehalose lipid may contain a structural unit derived from an alkylene oxide adduct in the substituents R1 and / or R2. In one embodiment of the present invention, the succinoyl trehalose lipid preferably has a structure with a low content of structural units derived from alkylene oxide adducts, from the viewpoint of maintaining the hydrophilic-hydrophobic balance of the entire molecular structure. Specifically, the content of structural units derived from alkylene oxide adducts in the substituents R1 and R2 in the general formula 1 is preferably 20% by mass or less, more preferably 10% by mass or less, even more preferably 5% by mass or less, and may be 0 parts by mass.
[0030] In one embodiment of the present invention, the critical micelle concentration (CMC) of the biosurfactant is set to 1000×10 from the viewpoint of excellent emulsification ability.-6 M or less is preferable, and 500×10 -6 M or less is more preferable, and 200×10 -6 It is more preferable that the critical micelle concentration of the biosurfactant is equal to or less than M. The critical micelle concentration of the biosurfactant can be calculated from the measured value by a conventional method using a high-performance surface tensiometer (e.g., DY-500 (manufactured by Kyowa Interface Science Co., Ltd.) to measure the surface tension by a platinum plate hanging plate method.
[0031] In one embodiment of the present invention, the biosurfactant preferably has a 50% cell growth inhibitory concentration (IC50) of 100 ppm or more, more preferably 300 ppm or more. The higher the IC50 of a biosurfactant, the lower the cytotoxicity of the biosurfactant. The IC50 of a biosurfactant is calculated based on the following formula: In vitro, 9(2), p185-190, 1995. Specifically, it can be determined by the method described in the Examples.
[0032] The α-gel-containing composition according to one embodiment of the present invention preferably contains the biosurfactant in an amount of 0.001% by mass or more relative to the total mass of the α-gel-containing composition. This makes it possible to obtain an α-gel-containing composition that is excellent in stability and has an excellent usability when used in cosmetics or pharmaceuticals (quasi-drugs). The content of the biosurfactant relative to the total mass of the α-gel-containing composition is more preferably 0.005% by mass or more, even more preferably 0.010% by mass or more, even more preferably 0.020% by mass or more, and particularly preferably 0.050% by mass or more. In addition, the upper limit of the content of the biosurfactant relative to the total mass of the α-gel-containing composition is not particularly limited, but is preferably 10.000% by mass or less, more preferably 5.000% by mass or less, and even more preferably 3.000% by mass or less.
[0033] Furthermore, in the α-gel-containing composition according to one embodiment of the present invention, the ratio of the content of the biosurfactant to the content of the higher alcohol, in terms of mass ratio, is preferably greater than 0 and less than 0.500, more preferably greater than 0 and less than 0.400, even more preferably greater than 0.001 and less than 0.300, and particularly preferably 0.002 to 0.200. If the ratio of the content of the biosurfactant to the content of the higher alcohol is within the above range, an α-gel-containing composition can be obtained that is excellent in stability and has an excellent feel when used in cosmetics or medicinal (quasi-drug) products.
[0034] (Method of producing biosurfactant) Examples of the method for producing the biosurfactant include a method including a culture step of culturing a microorganism in a medium containing a carbon source, a precipitation step of precipitating a product obtained by the culture step, an extraction step of extracting an extract containing a biosurfactant from the precipitate obtained by the precipitation step, and a fat-soluble substance removal step of removing fat-soluble substances from the extract obtained by the extraction step.
[0035] In the above-mentioned culture step, the step of culturing a microorganism in a medium containing a carbon source is carried out according to a conventional method. If necessary, nutrients such as a nitrogen source and inorganic salts may be added to the medium containing the carbon source.
[0036] The "microorganism" in the culture step is not particularly limited as long as it is capable of producing a biosurfactant, but is preferably a microorganism belonging to the genus Rhodococcus, and more preferably Rhodococcus erythropolis SD-74 strain, Rhodococcus sp. TB-42 strain, or Rhodococcus baiconulensis NBRC 100611 strain, since they are capable of producing succinoyl trehalose lipid.
[0037] The "carbon source" in the culture step is preferably a carbon compound that the microorganism assimilates during culture, particularly natural fats and oils, hydrocarbons, fatty acids, fatty acid esters, or higher alcohols. Here, the carbon compound is intended to mean a compound of carbon with hydrogen, nitrogen, or the like. The carbon source used in the culture step may be, for example, natural fats and oils, and may be either animal fats and oils or vegetable fats and oils, but is preferably vegetable fats and oils because they are more easily available. The vegetable fats and oils used in the culture step are preferably, for example, palm oil, coconut oil, soybean oil, olive oil, safflower oil, rapeseed oil, corn oil, cottonseed oil, tall oil, etc., but are not limited thereto.
[0038] In addition, a hydrocarbon can be used as a carbon source in the culture step. As the hydrocarbon used as a carbon source, normal alkanes such as n-decane, n-undecane, n-tridecane, n-tetradecane, n-pentadecane, n-hexadecane, n-heptadecane, n-octadecane, and n-nonadecane, and normal alkenes such as 1-decene, 1-undecene, 1-dodecene, 1-tridecene, 1-tetradecene, 1-pentadecene, 1-hexadecene, 1-heptadecene, and 1-octadecene can be preferably used.
[0039] In the culture step, fatty acids can also be used as a carbon source. Fatty acids used as carbon sources include decanoic acid, undecanoic acid, dodecanoic acid (lauric acid), tridecanoic acid, tetradecanoic acid (myristic acid), pentadecanoic acid, hexadecanoic acid (palmitic acid), heptadecanoic acid, octadecanoic acid (stearic acid), and oleic acid. In addition, fatty acid esters, undecyl alcohol, dodecyl alcohol (lauryl alcohol), and other higher alcohols may also be used as carbon sources.
[0040] As the carbon source to be added to the medium, the above-mentioned carbon sources are preferably used. The concentration of the carbon source added in the medium is preferably 5 to 20% by mass, more preferably 10% by mass. In addition to the above-mentioned carbon sources, a nitrogen source is preferably added to the medium used in the culturing step. As the nitrogen source to be added to the medium, a nitrogen-containing organic or inorganic substance that is usually used in culturing microorganisms is used, and for example, sodium nitrate, potassium nitrate, potassium hydrogen phosphate, potassium dihydrogen phosphate, etc. can be used. In addition to the above, nutrients such as yeast extract and peptone may be added to the medium if necessary for the growth of the microorganism.
[0041] The culture of the microorganism in the culture step is preferably carried out under aerobic conditions by shaking and stirring. The culture temperature is preferably 20°C to 35°C, and more preferably 30°C. The culture pH is preferably 5.5 to 9.5. The culture period is preferably until a mixture containing a biosurfactant (e.g., succinoyl trehalose lipid) at a concentration of 15 g / l to 150 g / l is produced.
[0042] In the culturing step, the microorganism may be seed-cultured before the main culture. By seed-culture of the microorganism, it is possible to adjust the microorganism to an optimal condition, and as a result, it is possible to efficiently produce a biosurfactant.
[0043] The precipitation step is a step of precipitating a product containing a biosurfactant produced by the microorganism in the culture step (for example, a product containing STL). That is, precipitation is performed on a medium or culture solution containing a biosurfactant produced in the medium by the microorganism. In this case, the medium or culture solution to be precipitated may be obtained by centrifuging a culture solution in which a microorganism has been cultured, and removing the bacterial cells and residual substrates from the culture solution. Here, "precipitating" refers to removing a substance dissolved in the medium as a solid. That is, in the precipitation step, the biosurfactant produced in the medium by the microorganism in the culture step can be removed as a solid from the medium.
[0044] In the precipitation step, the method of precipitating the product containing the biosurfactant is not particularly limited as long as it is a method that can separate the product containing the biosurfactant as a solid from the culture solution, and a conventional method can be used. For example, when precipitating a product containing an anionic biosurfactant, the medium in which the microorganism was cultured in the culture step is acidified, and the acidic substance in the medium is precipitated to precipitate the product containing the acidic anionic biosurfactant (acid precipitation). Specifically, the product containing the anionic biosurfactant can be precipitated by lowering the pH in the culture solution (target). In order to lower the pH of the culture solution, an acidic substance, for example, HCl, may be added. Thereafter, the precipitated product can be taken out, for example, by performing a centrifugation process. Hereinafter, the product obtained through the precipitation step is referred to as a "precipitated product".
[0045] The extraction step is a step of extracting a biosurfactant from a precipitated product. For example, in the extraction step of extracting an anionic biosurfactant having a glycolipid structure, a solvent that is incompatible with water and in which an anionic biosurfactant, particularly a glycolipid, is soluble is added to the precipitated product, thereby dissolving the anionic biosurfactant contained in the precipitated product in a solvent layer. Then, the solvent layer in which the anionic biosurfactant is dissolved can be separated to obtain an anionic biosurfactant composition from which water-soluble substances have been removed. The term "water-soluble substance" refers to a substance that is soluble in water, and can be said to be water-soluble impurities such as salts contained in the solid precipitate precipitated from the medium together with water. Here, the term "salt" refers to a compound in which the hydrogen atom of an acid is replaced with a metal or other metallic group.
[0046] The above-mentioned precipitated product precipitated from the culture medium in which the microorganism is cultured contains water and contains a large amount of water-soluble impurities. Such precipitated products further contain fat-soluble impurities and are solid, so that it is difficult to sufficiently remove the water-soluble substances contained in the precipitate even if they are washed with water. However, by carrying out an extraction process using a solvent that is incompatible with water and dissolves the anionic biosurfactant, it is possible to obtain an anionic biosurfactant composition from which the water-soluble substances have been sufficiently removed.
[0047] In the extraction step, it is not necessary to completely remove the water-soluble substances from the precipitated product, which is the object to be extracted by adding a solvent, and it is sufficient that the amount of water-soluble substances in the precipitated product is reduced before and after the extraction treatment, thereby making it possible to obtain an anionic biosurfactant composition with a reduced content of impurities.
[0048] In the extraction step, the solvent to be added to the precipitated product may be a solvent that is incompatible with other solvents (e.g., water) capable of dissolving water-soluble substances and that dissolves the anionic biosurfactant. Examples of such solvents include ester-based solvents, alcohol-based solvents, and hydrocarbon-based solvents, and more specifically, ethyl acetate, 1-butanol, xylene, etc. The amount of the solvent to be added to the precipitated product is preferably 0.1 to 10 times the amount of the precipitated product by mass, and more preferably equal to the amount of the precipitated product.
[0049] The extraction step will be described using an example in which ethyl acetate is used as a solvent. First, the culture product is precipitated from the culture liquid, and ethyl acetate, which is a solvent, is added to the precipitated precipitated product and thoroughly stirred to separate the solution containing the precipitated product into two layers, an ethyl acetate layer and an aqueous layer. Next, the ethyl acetate layer formed in the upper layer is separated using a separating funnel or the like. Since water-soluble substances are not dissolved in the ethyl acetate layer and an anionic biosurfactant is dissolved in the ethyl acetate layer, it is possible to remove the water-soluble substances from the precipitated product by separating the ethyl acetate layer. Next, for example, an evaporator is used to remove ethyl acetate from the ethyl acetate layer, thereby obtaining a solid anionic biosurfactant composition from which the water-soluble substances have been removed.
[0050] In the above description, the precipitation step and the extraction step are performed in sequence, but the present invention is not limited to this. For example, it is possible to obtain a biosurfactant composition from which water-soluble substances have been removed by adding a solvent to the culture medium or culture solution in which the culture product has been dissolved and separating the solvent layer, without precipitating the culture product from the culture medium or culture solution. In this case, the culture solution in which the microorganism has been cultured may be centrifuged to remove the bacterial cells and the remaining substrate, and the resulting product may be used as the target from which water-soluble substances are removed using a solvent. That is, in the extraction step, the target substance from which water-soluble substances are removed using a solvent may be a culture medium or culture solution containing a biosurfactant produced in the culture medium by the microorganism during culture, or a mixture containing a solid biosurfactant separated from the reaction system.
[0051] The product containing the anionic biosurfactant obtained through this extraction process is referred to as the "extraction product."
[0052] The fat-soluble substance removal step is a step of removing fat-soluble substances from the extraction product. Here, the term "fat-soluble substance" refers to a substance that is soluble in fats and oils.
[0053] The method for removing fat-soluble substances from the solid extract product from which the water-soluble substances have been removed is not particularly limited as long as it is a method capable of separating the biosurfactant from the fat-soluble substances, and any conventional method can be used. For example, first, the solvent is distilled off from the extract product, and then a solvent capable of separating the biosurfactant from the fat-soluble substances is added to the solid obtained by distilling off the solvent, and the solvent layer is removed to obtain a biosurfactant from which the fat-soluble substances have been removed. This allows fat-soluble impurities to be efficiently removed from the extract product.
[0054] In the fat-soluble substance removal step, the solvent capable of separating the biosurfactant from the fat-soluble substance is a solvent in which the biosurfactant is poorly soluble or insoluble and the fat-soluble substance is soluble. For example, when hexane is used as such a solvent, the water-soluble substance is removed from the precipitate product precipitated from the culture solution using the solvent, and then the solid (extraction product) obtained by distilling off the solvent is suspended in hexane and filtered or centrifuged to remove the hexane. This allows fat-soluble impurities to be efficiently removed from the extraction product containing the biosurfactant.
[0055] (Higher alcohol) The α-gel-containing composition according to one embodiment of the present invention contains a biosurfactant and a higher alcohol. In this specification, a higher alcohol refers to a monohydric chain saturated alcohol having 6 or more carbon atoms. The higher alcohol may be a linear monohydric chain saturated alcohol or a branched monohydric chain saturated alcohol. The higher alcohol may be a primary alcohol, a secondary alcohol, or a tertiary alcohol. Examples of the higher alcohols include n-hexyl alcohol, n-heptyl alcohol, n-octyl alcohol, n-nonyl alcohol, n-decyl alcohol, n-undecyl alcohol, n-heptyl alcohol, lauryl alcohol, n-tridecyl alcohol, myristyl alcohol, n-pentadecyl alcohol, cetyl alcohol (cetanol), margaryl alcohol, stearyl alcohol, behenyl alcohol, n-nonadecyl alcohol, arachidyl alcohol, ceryl alcohol, melissyl alcohol, palmitoleyl alcohol, oleyl alcohol, eicosenyl alcohol, 2-methylpentyl alcohol, 2-ethylbutyl alcohol, 2-ethylhexyl alcohol, methylamyl alcohol, capryl alcohol, diisobutyl carbinol, isostearyl alcohol, octyldodecanol, and mixtures of two or more of these.
[0056] Among these, from the viewpoint of α-gel formation, the higher alcohol preferably has a carbon number of 10 or more, even more preferably 12 or more, particularly preferably 14 or more, and most preferably 16 or more. There is no particular upper limit on the carbon number, but it is, for example, 24 or less, more preferably 22 or less, and even more preferably 20 or less. Furthermore, from the viewpoint of α-gel formation, the higher alcohol is more preferably a linear monohydric chain saturated alcohol, and from the viewpoint of α-gel formation, it is more preferably a primary alcohol.
[0057] In one embodiment of the present invention, more preferred examples of the higher alcohol include myristyl alcohol, cetanol, stearyl alcohol, behenyl alcohol, and mixtures of two or more of these, which are more preferred from the viewpoint of α-gel formation.
[0058] In one embodiment of the present invention, the higher alcohol preferably contains at least one of a higher alcohol having 16 carbon atoms and a higher alcohol having 18 carbon atoms. This is preferable because it provides a better feeling when used in cosmetics or pharmaceuticals (quasi-drugs). Examples of such higher alcohols include cetanol or a mixture of cetanol and other higher alcohols, stearyl alcohol or a mixture of stearyl alcohol and other higher alcohols, a mixture of cetanol and stearyl alcohol, or a mixture of the mixture and other higher alcohols. When the higher alcohol contains a higher alcohol having 16 carbon atoms and a higher alcohol having 18 carbon atoms, the ratio of the higher alcohol having 16 carbon atoms to the higher alcohol having 18 carbon atoms is preferably 90:10 to 10:90, more preferably 80:20 to 20:80, even more preferably 70:30 to 20:80, even more preferably 60:40 to 20:80, and particularly preferably 55:45 to 20:80. More specific examples of such higher alcohols include a combination of cetanol and stearyl alcohol in the above-mentioned ratio, or cetearyl alcohol, which is a mixture of cetanol and stearyl alcohol.
[0059] (Oil) The α-gel-containing composition according to one embodiment of the present invention may further contain an oil in addition to the biosurfactant and the higher alcohol. By including an oil, the α-gel-containing composition according to one embodiment of the present invention can emulsify the oil in a gel composed of α-hydrate crystals and an aqueous phase to form a homogeneous gel consisting of three phases: α-hydrate crystals, an aqueous phase, and an oil phase. In addition, by forming a homogeneous gel consisting of three phases: α-hydrate crystals, an aqueous phase, and an oil phase, the stability of the composition can be further improved, which is preferable.
[0060] The oil is preferably a liquid or paste-like oil at 25° C. under 1 atmosphere, and particularly preferably a liquid oil.
[0061] Examples of the liquid oil agent include waxes, hydrocarbons, higher alcohol esters, higher fatty acid esters, triglycerides, silicone oils, higher fatty acids, animal and vegetable oils, cholesterol fatty acid esters, sterols, sterol esters, polyphenols, etc. More preferred specific examples include waxes such as cownauba wax, candelilla wax, jojoba oil, beeswax, and lanolin; hydrocarbons such as mineral oil, isododecane, squalane, petrolatum, ceresin, and microcrystalline wax; esters such as isopropyl palmitate, isopropyl myristate, isooctyl myristate, isotridecyl myristate, octadecyl myristate, octyldodecyl myristate, cholesteryl isostearate, triethylhexanoin, cetyl ethylhexanoate, and tri(caprylic / capric)glyceryl; Examples of such oils include ethers, dimethyl silicone oils such as octamethyltrisiloxane and dimethicone, cyclic silicone oils such as cyclotetrasiloxane, cyclopentasiloxane, cyclohexasiloxane, cyclomethicone and methylpolycyclosiloxane, methylphenyl silicone oils such as polyether-modified silicone oil and methylphenylpolysiloxane, mineral oils, vegetable oils such as sunflower oil, olive oil, jojoba oil, camellia oil, grapeseed oil, avocado oil, macadamia nut oil, almond oil, rice germ oil, clove oil, orange oil and spruce oil, triglycerides, etc. These oils may be used alone or in combination of two or more.
[0062] In an α-gel-containing composition according to one embodiment of the present invention, which contains an oil in addition to a biosurfactant and a higher alcohol, the ratio of the content of the oil to the content of the higher alcohol, in mass ratio, is preferably greater than 0 and less than 800, more preferably greater than 0 and less than 150, even more preferably greater than 0 and less than 100, particularly preferably 0.05 to 80.0, may be 0.1 to 80.0, or may be 0.5 to 80.0. If the ratio of the content of the oil to the content of the higher alcohol is within the above range, the stability of the α-gel-containing composition can be further improved, which is preferable.
[0063] From the viewpoint of providing a superior feel when used in cosmetics or pharmaceuticals (quasi-drugs), the α-gel-containing composition of one embodiment of the present invention preferably contains, in addition to a biosurfactant, a higher alcohol, and an oil, a polyhydric alcohol and / or a thickener, as described below.
[0064] (Polyhydric alcohol) The α-gel-containing composition according to one embodiment of the present invention may further contain a polyhydric alcohol in addition to the biosurfactant and the higher alcohol. By containing a polyhydric alcohol, the α-gel-containing composition according to one embodiment of the present invention is preferable because it has a better feel when used in cosmetics or pharmaceuticals (quasi-drugs). In addition, it has been found that the particle size of the α-gel-containing composition tends to be finer by containing a polyhydric alcohol. The finer particle size of the α-gel-containing composition has the further advantage of stabilizing the emulsion particles and improving skin compatibility.
[0065] The polyhydric alcohol is not particularly limited, but examples thereof include propylene glycol, dipropylene glycol, 1,3-butylene glycol, pentylene glycol, glycerin, polypropylene glycol, diglycerin, polyglycerin, ethylene glycol, diethylene glycol, polyethylene glycol, 1,3-propanediol, sorbitol, etc. These may be used alone or in combination of two or more kinds.
[0066] In an α-gel-containing composition according to one embodiment of the present invention, which contains a polyhydric alcohol in addition to a biosurfactant and a higher alcohol, the ratio of the content of the polyhydric alcohol to the content of the higher alcohol is preferably 0.1 or more, more preferably 1.0 or more, even more preferably 3.0 or more, and particularly preferably 5.0 or more, by mass ratio. The upper limit of the mass ratio is not particularly limited, but is, for example, 100.0. If the ratio of the content of the polyhydric alcohol to the content of the higher alcohol is within the above range, the stability of the α-gel-containing composition can be further improved, which is preferable.
[0067] From the viewpoint of providing a superior feel when used in cosmetics or pharmaceuticals (quasi-drugs), the α-gel-containing composition according to one embodiment of the present invention preferably further contains, in addition to a biosurfactant, a higher alcohol, and a polyhydric alcohol, the oil agent and / or a thickener described below.
[0068] (Thickener) The α-gel-containing composition according to one embodiment of the present invention may further contain a thickener in addition to the biosurfactant and the higher alcohol. By containing a thickener, the α-gel-containing composition according to one embodiment of the present invention is preferably because separation of the aqueous phase is further suppressed and the stability is improved.
[0069] The thickener is not particularly limited, but examples thereof include xanthan gum, carbomer, hydroxyethyl cellulose, methyl cellulose, ethyl cellulose, gum arabic, gellan gum, sclerotium gum, etc. These may be used alone or in combination of two or more kinds.
[0070] In the α-gel-containing composition according to one embodiment of the present invention, which contains a biosurfactant, a higher alcohol, and a thickener, the ratio of the content of the thickener to the content of the higher alcohol is preferably 0.01 or more, more preferably 0.03 or more, even more preferably 0.05 or more, and particularly preferably 0.10 or more, by mass ratio. The upper limit of the mass ratio is not particularly limited, but is, for example, 10.00. If the ratio of the content of the thickener to the content of the higher alcohol is within the above range, the stability of the α-gel-containing composition can be further improved, which is preferable.
[0071] From the viewpoint of providing a superior feel when used in cosmetics or pharmaceuticals (quasi-drugs), the α-gel-containing composition according to one embodiment of the present invention preferably further contains the oil and / or the polyhydric alcohol in addition to the biosurfactant, higher alcohol, and thickener.
[0072] (Other Ingredients) The α-gel-containing composition according to one embodiment of the present invention may contain other components in addition to a biosurfactant, a higher alcohol, and, if necessary, at least one selected from the group consisting of oils, polyhydric alcohols, and thickeners, as long as they do not adversely affect the effects of the present invention. The other components include, but are not limited to, UV absorbers, antioxidants, emollients, emulsifiers, solubilizers, anti-inflammatory agents, moisturizers, preservatives, pH adjusters, dyes, fragrances, powders, etc. The emulsifier is intended to be an emulsifier other than the biosurfactant, and for example, various anionic surfactants, cationic surfactants, amphoteric surfactants, and nonionic surfactants can be used.
[0073] The content of the other components is not particularly limited as long as it does not adversely affect the effects of the present invention, and is, for example, 0 to 99% by mass relative to the total mass of the α-gel-containing composition.
[0074] (water) The α-gel-containing composition according to one embodiment of the present invention contains a biosurfactant, a higher alcohol, and, optionally, at least one selected from the group consisting of an oil, a polyhydric alcohol, and a thickener, and, optionally, the other components described above, with the remainder being water.
[0075] In one embodiment of the present invention, the amount of water contained in the α-gel-containing composition is not particularly limited, but is preferably 1% by mass to 99% by mass, more preferably 5% by mass to 95% by mass, and even more preferably 10% by mass to 90% by mass, relative to the total mass of the α-gel-containing composition.
[0076] The water content of the α-gel-containing composition is preferably 1% by mass or more from the viewpoint of α-gel formation, and is preferably 99% by mass or less from the viewpoint of α-gel formation.
[0077] In one embodiment of the present invention, the water used may suitably be distilled water, ion-exchanged water, tap water, or the like.
[0078] (pH of α-gel-containing composition) The α-gel-containing composition according to one embodiment of the present invention preferably has a pH of 5.0 or higher. A pH of 5 or higher is preferable because the stability of the α-gel-containing composition is excellent. The pH of the α-gel-containing composition is more preferably 6.0 or higher. The pH of the α-gel-containing composition is preferably 12.0 or lower, more preferably 11.5 or lower, and even more preferably 11.0 or lower.
[0079] The pH of the α-gel-containing composition according to one embodiment of the present invention can be adjusted by adding a pH adjuster when preparing the α-gel-containing composition. Examples of pH adjusters that adjust the α-gel-containing composition to the alkaline side include sodium hydroxide, sodium bicarbonate, potassium hydroxide, magnesium hydroxide, triethanolamine, arginine, sodium citrate, sodium lactate, and disodium succinate. Examples of pH adjusters that adjust the α-gel-containing composition to the acid side include citric acid, lactic acid, malic acid, and the like, or salts thereof.
[0080] (Average particle size of α-gel-containing composition) The average particle size of the α-gel-containing composition according to one embodiment of the present invention is preferably 200.0 μm or less, more preferably 100.0 μm or less, and even more preferably 50.0 μm or less.
[0081] Here, the average particle size of the α-gel-containing composition refers to the average particle size of oil particles surrounded by an association of lamellar multilayer films, and is a dimension that includes the multilayer films.
[0082] It is preferable from the viewpoint of emulsion stability that the average particle size of the α-gel-containing composition is 200.0 μm or less.
[0083] Here, the average particle size of the α-gel-containing composition means the median size (volume basis), and is a value measured by the method described in the examples below.
[0084] [2. Method for producing α-gel-containing composition] The method for producing an α-gel-containing composition according to one embodiment of the present invention is not particularly limited as long as it is a method that can produce the desired α-gel-containing composition, and various methods can be adopted.
[0085] The manufacturing method of an α-gel-containing composition according to one embodiment of the present invention will be described below using an α-gel-containing composition containing a biosurfactant, a higher alcohol, and an oil as an example. The manufacturing method of such an α-gel-containing composition can include an oil phase preparation step of preparing an oil phase containing a biosurfactant, a higher alcohol, and an oil, an aqueous phase preparation step of separately preparing an aqueous phase containing water, and an emulsification step of mixing and emulsifying the aqueous phase and the oil phase.
[0086] In the oil phase preparation step, the method of preparing the oil phase containing the biosurfactant, the higher alcohol, and the oil agent is not particularly limited as long as it is a method that can mix these components. For example, a method of mixing the biosurfactant and the higher alcohol to dissolve them in each other and then adding the oil agent to this mixture can be preferably adopted. However, the order in which each component is mixed is not limited to this, and any order may be used. In addition, the temperature at which each component is mixed in the oil phase preparation step is not particularly limited, and it may be a temperature at which each component dissolves in each other.
[0087] The aqueous phase preparation step is not particularly limited as long as it is a method that can mix water and, if necessary, water-soluble components such as polyhydric alcohols and pH adjusters. The order in which the components are mixed is not particularly limited, and any order is acceptable. In addition, the temperature at which the components are mixed in the aqueous phase preparation step is not particularly limited, and any temperature at which the components dissolve in each other is sufficient. The pH of the aqueous phase obtained in the aqueous phase preparation step is preferably 5.0 or higher, more preferably 6.0 or higher.
[0088] The emulsification step is not particularly limited as long as it is a step that can emulsify the aqueous phase obtained in the aqueous phase preparation step and the oil phase obtained in the oil phase preparation step. Preferably, the aqueous phase and the oil phase are mixed and stirred at 40°C to 90°C, more preferably 60°C to 90°C. The method of mixing the aqueous phase and the oil phase is not particularly limited, and the oil phase may be added to the aqueous phase, or the aqueous phase may be added to the oil phase. The addition method is also not particularly limited, and the mixture may be added gradually or all at once. It is more preferable that the aqueous phase and the oil phase are heated to 40°C to 90°C, more preferably 60°C to 90°C, when mixed. The method of mixing and stirring the aqueous phase and the oil phase is not particularly limited, and the mixture may be stirred using a homomixer, homodisper, three-one motor, or the like. Among them, a homomixer is more preferably used. The stirring speed at which the aqueous phase and the oil phase are mixed and stirred is also not particularly limited, and is, for example, 1000 rpm or more, more preferably 2000 rpm or more. The stirring time is not particularly limited, but is, for example, 10 seconds or more, and more preferably 1 minute or more.
[0089] After the aqueous phase and the oil phase are emulsified in the emulsification step, it is preferable to cool the obtained α-gel-containing composition while stirring it, either by leaving it to cool or by cooling it with a cooling device.
[0090] [3. Use of α-gel-containing composition] The α-gel-containing composition according to one embodiment of the present invention has excellent stability and excellent usability when used in cosmetics or medicinal (quasi-drug) products, and therefore can be suitably used in cosmetics or medicinal (quasi-drug) products. In other words, one aspect of the present invention also includes cosmetics or medicinal (quasi-drug) products that contain the α-gel-containing composition according to one embodiment of the present invention.
[0091] Examples of cosmetics or medicinal (quasi-drug) products according to one embodiment of the present invention include, but are not limited to, skin cosmetics (lotion, serum, emulsion, cream, etc.), lipstick, sunscreen cosmetics, makeup cosmetics, etc. The α-gel-containing composition according to one embodiment of the present invention is preferably used in aqueous cosmetics such as lotion, serum, emulsion, cream pack / mask, pack, hair washing cosmetics, fragrance cosmetics, liquid body cleanser, UV care cosmetics, deodorant cosmetics, oral care cosmetics, etc. (in the case of cosmetics).
[0092] A cosmetic or medicinal (quasi-drug) product according to one embodiment of the present invention may contain a solvent such as water and / or other additives in addition to the α-gel-containing composition according to one embodiment of the present invention.
[0093] Examples of other additives that may be contained in the cosmetic or quasi-drug according to one embodiment of the present invention include oils and fats, waxes, mineral oils, fatty acids, alcohols, esters, metal soaps, gums and water-soluble polymer compounds, vitamins, amino acids, skin whitening agents, moisturizing agents, hair growth agents, α-hydroxy acids, inorganic pigments, UV absorbers, astringents, antioxidants, anti-inflammatory agents, bactericides and disinfectants, fragrances, dyes and colorants, hormones, sequestering agents, pH adjusters, chelating agents, preservatives and antifungal agents, cooling agents, stabilizers, animal and vegetable proteins and decomposition products thereof, animal and vegetable polysaccharides and decomposition products thereof, animal and vegetable glycoproteins and decomposition products thereof, blood flow promoters, anti-inflammatory agents and anti-allergic agents, cell activators, keratolytic agents, wound healing agents, foaming agents, thickeners, oral agents, and deodorizers and deodorants. EXAMPLES
[0094] Hereinafter, one embodiment of the present invention will be described in more detail with reference to examples and comparative examples, but the present invention is not limited to these.
[0095] [Materials used] (Surfactant) Biosurfactant: STL C14 Glyceryl stearate (NIKKOL MGS-BV2, manufactured by Nikko Chemicals Co., Ltd.) (Higher alcohol) Cetearyl alcohol (Kao Corporation, Kalcol 6850) Cetanol (Kao Corporation, Kalcol 6098) Stearyl alcohol (Kao Corporation, Kalcol 8098) Behenyl alcohol (Kao Corporation, Kalcol 220-80) (Oil) Microcrystalline wax (refined microcrystalline wax, manufactured by Nikko Rika Corporation) Dimethicone (KF-96A-6CS, manufactured by Shin-Etsu Chemical Co., Ltd.) Squalane (Olive Squalane, manufactured by Kokyu Alcohol Kogyo Co., Ltd.) 2-Cetyl ethylhexanoate (manufactured by Koyu Alcohol Kogyo Co., Ltd., CEH) (Polyhydric alcohol) 1,3-Butylene glycol (Daicel Corporation, 1,3BG) Glycerin (concentrated glycerin for cosmetics, manufactured by Sakamoto Pharmaceutical Co., Ltd.) Pentylene glycol (Diol PD, manufactured by Kokyu Alcohol Kogyo Co., Ltd.) (Thickener) Xanthan gum (KELTROL CG-BT, manufactured by Sansho Co., Ltd.) Carbomer (Lubrizol, Carbopol 980) [Getting STL C14] According to the method described in Y. Uchida et al., Agric. Biol. Chem., 53(3):765-769 (1989), Rhodococcus erythropolis SD-74 strain was seed cultured under the following conditions. The Rhodococcus erythropolis SD-74 strain used in this example was isolated as a vegetable oil-utilizing bacterium and was approved by the National Institute of Technology and Evaluation (NITE) in Japan. It has been deposited at the Patent Microorganisms Depositary Center under accession number: NITE P-03788.
[0096] Rhodococcus erythropolis SD-74 strain was inoculated into 100 ml of FPY medium (2% fructose (Fujifilm Wako Pure Chemical Industries, Ltd.), 0.5% polypeptone (Fujifilm Wako Pure Chemical Industries, Ltd.), 0.5% yeast extract powder (Oxoid Corporation), 0.1% NaNO3 (Fujifilm Wako Pure Chemical Industries, Ltd.), 0.1% KH2PO4 (Fujifilm Wako Pure Chemical Industries, Ltd.), 0.1% MgSO4-7H2O (Fujifilm Wako Pure Chemical Industries, Ltd.)) in a 500 ml Sakaguchi flask and cultured with shaking at 30°C for 72 hours to obtain a seed culture solution.
[0097] 6300 ml of modified MedD medium (per 1 L, 5.44 g of KH2PO4 (FUJIFILM Wako Pure Chemicals), 10.45 g of K2HPO4 (FUJIFILM Wako Pure Chemicals), 3 g of KNO3 (FUJIFILM Wako Pure Chemicals), 0.1 g of MgSO4-7H2O (FUJIFILM Wako Pure Chemicals), 3 g of yeast extract powder (Oxoid) and 900 ml of pure water) were sterilized at high temperature and high pressure, 700 ml of tetradecane (Tokyo Chemical Industry Co., Ltd.) that had been separately sterilized at high temperature and high pressure was added, 140 ml of the seed culture solution was inoculated, and main culture was started under the following conditions. Using a 10 L jar culture tank (Able), culture was performed at a culture temperature of 30°C while stirring at 300 rpm. During the culture, the pH of the medium was maintained at 7.0 by adding 50% KOH (FUJIFILM Wako Pure Chemicals).
[0098] After 360 hours of cultivation, 3700 ml of the culture solution was centrifuged at 6500 rpm for 60 minutes to remove the bacterial cells and remaining substrates, and then 150 ml of 6N HCl (Fujifilm Wako Pure Chemical Industries, Ltd.) was added to adjust the pH of the solution to 2.98, resulting in the deposition of a white gel-like precipitate in the solution. This solution was centrifuged at 6500 rpm for 30 minutes to remove the liquid layer, resulting in the deposition of a precipitate with a wet weight of 760 g.
[0099] 760 g of ethyl acetate (FUJIFILM Wako Pure Chemical Industries, Ltd.) was added to the obtained precipitate and thoroughly stirred. The solution separated into an aqueous layer and an ethyl acetate layer was separated using a separatory funnel, and the upper ethyl acetate layer was collected. Ethyl acetate was removed from the collected ethyl acetate solution using an evaporator. The solid obtained by removing ethyl acetate was suspended in an equal amount of hexane (FUJIFILM Wako Pure Chemical Industries, Ltd.), and the suspension was centrifuged to remove the hexane. This process was repeated three times. The liquid obtained by removing hexane was dried using an evaporator, and 100 g of a white solid (STL C14) was obtained.
[0100] The resulting STL C14 is a succinoyltrehalose lipid having a carboxyl group produced using tetradecane as a carbon source.
[0101] [Physical properties of STL C14] (Measurement of Critical Micelle Concentration (CMC) of STL C14) Surface tension measurements were performed using a high-performance surface tensiometer (DY-500 (Kyowa Interface Science Co., Ltd.) using the platinum plate hanging plate method. STL C14, STL C16, and STL The critical micelle concentrations (CMC) of C18, sodium lauryl sulfate, sodium deoxycholate, and sodium caprylate were calculated.
[0102] The CMC of the obtained STL C14 was 2.2 × 10 -5 It was M.
[0103] (Cytotoxicity test of STL C14) Cytotoxicity tests were performed according to the method described in L. Vian, J. Vinvent, J. Maurin, I. Fabre, J. Giroux, JP Cano, Toxicol in vitro, 9(2), p185-190,1995. Using STL C14, STL sample-added media were prepared so that the final STL concentration was 1 mass ppm, 5 mass ppm, 10 mass ppm, 25 mass ppm, 50 mass ppm, 100 mass ppm, 250 mass ppm, 500 mass ppm, or 1000 mass ppm. L929 mouse fibroblasts (KAC) were cultured at 2.0 × 10 in DMEM medium (Fujifilm Wako Pure Chemical Industries, Ltd.) containing heat-inactivated fetal bovine serum (final concentration 10%). 5 A cell suspension was prepared at 150μL / well and L929 mouse fibroblast cells were seeded in a 96-well multiwell plate (Thermo Fisher). Three technical replicates were performed in the cell culture experiment. After culturing for 24 hours at 37℃ in a 5% CO2 atmosphere, the STL sample-supplemented medium was added at 150μL / well.
[0104] After 24 hours of culture at 37°C under a 5% CO2 atmosphere, the medium was discarded, and DMEM medium containing Neutral Red (Fujifilm Wako Pure Chemical) added to a final concentration of 50 μg / mL was added at 150 μL / well. After 3 hours of culture at 37°C under a 5% CO2 atmosphere, the medium was discarded, and the cells were washed with D-PBS(-) solution (Fujifilm Wako Pure Chemical). A 50% ethanol solution was prepared using ethanol (Fujifilm Wako Pure Chemical), and glacial acetic acid (Fujifilm Wako Pure Chemical) was added to the 50% ethanol solution to a final concentration of 1%. This 1% glacial acetic acid ethanol solution was added at 100 μL / well to fix the cells. After 5 minutes, the absorbance at 546 nm was measured using a corona multi-grating microplate reader SH-9000Lab (Hitachi High-Tech Science), and the live cells that had taken up Neutral Red were quantified. The 50% cell growth inhibitory concentration (IC50) was calculated as an evaluation score of cytotoxicity.
[0105] The obtained IC50 of STL C14 was 344.
[0106] [Example 1] 0.100 parts by mass of biosurfactant and 3,000 parts by mass of cetearyl alcohol as a higher alcohol were mixed at 80°C to 85°C to obtain a solution in which the biosurfactant was dissolved in the higher alcohol. 50,000 parts by mass of squalane as an oil agent was added to the obtained solution, and the solution was heated to 80°C to 85°C to obtain an oil phase.
[0107] Separately, 46.590 parts by mass of purified water was mixed with 0.013 parts by mass of sodium hydroxide and heated to 80°C to 85°C to prepare an aqueous phase.
[0108] The oil phase was gradually added to the aqueous phase while stirring at 3000 rpm using a homomixer, and after the entire amount was added, the mixture was stirred at 5000 rpm for 5 minutes. Immediately after the mixture was emulsified, 10.000 parts by mass (0.200 parts by mass as xanthan gum) of a 2% aqueous solution was added as a thickener. Then, the mixture to which the thickener was added was cooled to 35°C while stirring at 1000 rpm to obtain a gel composition. The X-ray diffraction pattern was confirmed to show that the obtained gel composition was an α-gel-containing composition.
[0109] [Example 2] A gel composition was obtained by the same procedure as in Example 1, except that 2,000 parts by mass of cetearyl alcohol and 1,000 parts by mass of behenyl alcohol were used instead of 3,000 parts by mass of cetearyl alcohol as the higher alcohol.
[0110] [Example 3] A gel composition was obtained by the same procedure as in Example 1, except that 2,100 parts by mass of cetanol and 0.900 parts by mass of stearyl alcohol were used instead of 3,000 parts by mass of cetearyl alcohol as the higher alcohol. As a result of checking the X-ray diffraction pattern, the obtained gel composition was found to be an α-gel-containing composition.
[0111] [Example 4] A gel composition was obtained by the same procedure as in Example 1, except that 50,000 parts by mass of 2-ethylhexanoate was used instead of 50,000 parts by mass of squalane as the oil agent.
[0112] [Example 5] A gel composition was obtained by the same procedure as in Example 1, except that 50,000 parts by mass of dimethicone was used instead of 50,000 parts by mass of squalane as the oil agent. As a result of checking the X-ray diffraction pattern, the obtained gel composition was found to be an α-gel-containing composition.
[0113] [Example 6] A gel composition was obtained by the same procedure as in Example 1, except that 50,000 parts by mass of squalane and 0.500 parts by mass of microcrystalline wax were used as the oil agent, and the amount of purified water was changed accordingly as shown in Table 1.
[0114] [Example 7] A gel composition was obtained by the same procedure as in Example 1, except that the amount of squalane used as the oil agent was changed from 50,000 parts by mass to 30,000 parts by mass, and the amount of purified water was accordingly changed as shown in Table 1. The X-ray diffraction pattern was confirmed, and the obtained gel composition was found to be an α-gel-containing composition.
[0115] [Example 8] In preparing the aqueous phase, 10,000 parts by mass of 1,3-butylene glycol (a polyhydric alcohol) was added, and the amount of purified water was changed accordingly as shown in Table 1. The same procedure as in Example 1 was carried out to obtain a gel composition.
[0116] Specifically, 36.590 parts by mass of purified water was mixed with 0.013 parts by mass of sodium hydroxide and 10.000 parts by mass of 1,3-butylene glycol (polyhydric alcohol), and heated to 80°C to 85°C to prepare the aqueous phase.
[0117] As a result of checking the X-ray diffraction pattern, the obtained gel composition was found to be an α-gel-containing composition.
[0118] [Example 9] A gel composition was obtained by the same procedure as in Example 8, except that 10,000 parts by mass of 1,3-butylene glycol (polyhydric alcohol) was changed to 10,000 parts by mass of glycerin (polyhydric alcohol).
[0119] [Example 10] A gel composition was obtained by the same procedure as in Example 8, except that 10,000 parts by mass of 1,3-butylene glycol (polyhydric alcohol) was changed to 10,000 parts by mass of pentylene glycol (polyhydric alcohol).
[0120] [Example 11] In preparing the aqueous phase, 10,000 parts by mass of 1,3-butylene glycol (a polyhydric alcohol) was added, and the amount of purified water was changed accordingly as shown in Table 1. The same procedure as in Example 5 was carried out to obtain a gel composition.
[0121] Specifically, 36.590 parts by mass of purified water was mixed with 0.013 parts by mass of sodium hydroxide and 10.000 parts by mass of 1,3-butylene glycol (polyhydric alcohol), and heated to 80°C to 85°C to prepare the aqueous phase.
[0122] As a result of checking the X-ray diffraction pattern, the obtained gel composition was found to be an α-gel-containing composition.
[0123] [Example 12] A gel composition was obtained by the same procedure as in Example 1, except that in addition to 0.100 parts by mass of biosurfactant, 0.100 parts by mass of glyceryl stearate (nonionic surfactant) was used as the surfactant, and the amount of purified water was changed accordingly as shown in Table 2.
[0124] Specifically, in preparing the oil phase, 0.100 parts by mass of a biosurfactant, 0.100 parts by mass of glyceryl stearate, and 3,000 parts by mass of cetearyl alcohol were mixed together to obtain a solution in which the surfactant was dissolved in a higher alcohol, and 50,000 parts by mass of squalane was added to the obtained solution as an oil agent and heated to 80°C to 85°C.
[0125] [Example 13] A gel composition was obtained by the same procedure as in Example 1, except that the amount of biosurfactant was changed from 0.100 parts by mass to 0.300 parts by mass, and the amounts of purified water and sodium hydroxide were accordingly changed as shown in Table 2. The X-ray diffraction pattern was confirmed to be an α-gel-containing composition.
[0126] [Example 14] A gel composition was obtained by the same procedure as in Example 1, except that the amount of biosurfactant was changed from 0.100 parts by mass to 0.030 parts by mass, and the amounts of purified water and sodium hydroxide were accordingly changed as shown in Table 2. The X-ray diffraction pattern was confirmed to be an α-gel-containing composition.
[0127] [Example 15] A gel composition was obtained by the same procedure as in Example 1, except that the amounts of biosurfactant and higher alcohol were changed to 1.5 times the amounts, and the amounts of purified water and sodium hydroxide were changed accordingly, as shown in Table 2.
[0128] Specifically, the amount of biosurfactant was changed from 0.100 parts by mass to 0.150 parts by mass, and the amount of cetearyl alcohol was changed from 3.000 parts by mass to 4.500 parts by mass. In addition, the amount of purified water was changed from 46.590 parts by mass to 45.030 parts by mass, and the amount of sodium hydroxide was changed from 0.013 parts by mass to 0.020 parts by mass.
[0129] [Example 16] A gel composition was obtained by the same procedure as in Example 1, except that no thickener (0.200 parts by mass of xanthan gum) was used and the amount of purified water was changed accordingly as shown in Table 2.
[0130] [Example 17] A gel composition was obtained by the same procedure as in Example 1, except that carbomer neutralized with sodium hydroxide (prepared by adding 0.100 parts by mass of sodium hydroxide to 10,000 parts by mass of a 2% aqueous solution of carbomer (0.200 parts by mass as carbomer)) was added instead of 0.200 parts by mass of xanthan gum as a thickener. The total amount of sodium hydroxide used in this case is shown in Table 2.
[0131] [Example 18] A gel composition was obtained by the same procedure as in Example 1, except that in the preparation of the aqueous phase, 0.029 parts by mass of citric acid was further added and the amount of purified water was changed accordingly as shown in Table 2.
[0132] Specifically, 46.560 parts by mass of purified water was mixed with 0.013 parts by mass of sodium hydroxide and 0.029 parts by mass of citric acid, and the mixture was heated to 80°C to 85°C to prepare the aqueous phase.
[0133] [Example 19] A gel composition was obtained by the same procedure as in Example 18, except that the amount of citric acid was changed from 0.029 parts by mass to 0.016 parts by mass.
[0134] [Example 20] A gel composition was obtained by the same procedure as in Example 18, except that the amount of citric acid was changed from 0.029 parts by mass to 0.009 parts by mass.
[0135] [Comparative Example 1] A gel composition was obtained by the same procedure as in Example 1, except that 0.100 parts by mass of biosurfactant was not added and the amount of purified water was changed accordingly as shown in Table 2. The X-ray diffraction pattern was confirmed, and the obtained gel composition did not contain α-gel.
[0136] [Comparative Example 2] A gel composition was obtained by performing the same operations as in Example 1, except that 0.100 part by mass of the biosurfactant was changed to 0.100 part by mass of glyceryl stearate (nonionic surfactant).
[0137] [Evaluation of Gel Composition] The gel compositions obtained in the examples and comparative examples were evaluated for whether they were α-gel-containing compositions, the average particle diameter was measured, and the stability and usability were evaluated by the methods shown below.
[0138] (Evaluation of Whether it is an α-Gel-Containing Composition) XRD measurement was performed under the following conditions, and α-gel formation was determined from the presence or absence of a sharp peak between 21° and 22° in the wide-angle region. Specifically, when a sharp peak was present between 21° and 22° in the wide-angle region, it was determined to be an α-gel-containing composition. (XRD Measurement) Apparatus: Smart Lab (manufactured by Rigaku Corporation) X-ray source: Cu K-α (1.5405 Å) Tube voltage: 45 kV Tube current: 200 mA (Average Particle Diameter) The average particle diameter was measured as the median diameter (volume basis) using a particle size measuring device LA-950V2 manufactured by HORIBA. The measurement was performed at room temperature.
[0139] (Stability Evaluation (1)) The gel compositions obtained in the examples and comparative examples were placed in a glass container with a lid, sealed, allowed to stand at 25°C for 1 hour, and then the state of the gel composition was observed and evaluated according to the following criteria. Note that having luster means that the gel composition has a lustrous state. A: No oil phase separation on the upper surface, with luster B: No oil phase separation on the upper surface, without luster C: Slight oil phase separation on the upper surface D: Oil phase separated on the upper surface (Stability Evaluation (2)) The gel compositions obtained in the Examples and Comparative Examples were placed in a glass container with a lid, sealed, and left to stand at 50° C. for one week. The state of the gel compositions was then observed and evaluated according to the following criteria: A: No lower phase separation (separation of the aqueous phase at the bottom) D: Lower phase separation (separation of the aqueous phase at the bottom) (Feeling of use) The feel when used was evaluated by five expert panelists. Specifically, the feel when the gel compositions obtained in the Examples and Comparative Examples were applied to the skin on the inside of the forearm was evaluated.
[0140] The evaluation was carried out according to the following criteria. "Rich" refers to a state in which the product feels thick and resistant when applied. The evaluation results of five panelists were averaged and rounded off to the nearest whole number to determine the "usage feel." 5: Very rich 4: Rich flavor 3: Slightly rich 2: Almost no body. 1: No richness (Evaluation Results) The evaluation results are shown in Tables 1 and 2 below, together with the amounts of each component. In the tables, the units of amounts are parts by mass. In Table 1, the median diameter is not measured for portions where no median diameter is listed. In Comparative Example 1, the gel composition separated, so the feeling of use was not evaluated.
[0141] [Table 1]
[0142] [Table 2]
[0143] [summary] From the examples, it was confirmed that a gel composition containing a biosurfactant and a higher alcohol formed an α-gel. Moreover, the obtained α-gel-containing composition had superior stability and usability compared to a gel composition obtained under similar conditions using glyceryl stearate (a nonionic surfactant) instead of a biosurfactant.
[0144] Furthermore, the α-gel-containing compositions obtained in Examples 8 to 11, in which polyhydric alcohol was used in addition to biosurfactants and higher alcohols, had a very excellent feel when used. Also, the α-gel-containing compositions obtained in Examples 8 to 11, in which polyhydric alcohol was used in addition to biosurfactants and higher alcohols, had a small average particle size, and it was found that the particle size of the α-gel-containing composition was finer. Furthermore, a comparison between Examples 16 and 17 showed that the α-gel-containing composition containing a thickener further suppressed separation of the aqueous phase, improving stability.
[0145] [Prescription example] Using the obtained biosurfactant STL C14, emulsion compositions of Formulation Examples 1 to 4 shown in Table 3 below were prepared.
[0146] (Adjustment method) Oil phase 1 and oil phase 2 were prepared by mixing and dissolving them at 80°C to 85°C in advance, and the two were mixed to prepare the oil phase. Separately, an aqueous phase was prepared by heating and mixing at 80°C to 85°C. Sodium hydroxide was added so that the pH of the aqueous phase became 8.
[0147] The oil phase was gradually added to the water phase while stirring at 3000 rpm using a homomixer, and after the entire amount was added, the mixture was stirred at 5000 rpm for 5 minutes. After that, the mixture was cooled to 55°C while stirring at 1000 rpm, and additives 1 and 2 were added at that point and cooled to 35°C to obtain an emulsion composition. This emulsion composition had a rich feel when applied and was excellent in usability.
[0148] [Table 3] [Industrial Applicability]
[0149] The α-gel-containing composition according to one embodiment of the present invention, which contains a biosurfactant and a higher alcohol, is excellent in stability and has an excellent feel when used in cosmetics or medicinal products (quasi-drugs). Therefore, the α-gel-containing composition according to one embodiment of the present invention can be widely used in cosmetics, medicinal products (quasi-drugs), etc. [Accession number]
[0150] NITE P-03788
Claims
1. An α-gel-containing composition comprising a biosurfactant and a higher alcohol.
2. The α-gel-containing composition according to claim 1 , wherein the biosurfactant comprises an anionic biosurfactant.
3. The α-gel-containing composition according to claim 1 , wherein the biosurfactant comprises a biosurfactant having a glycolipid structure.
4. The α-gel-containing composition according to claim 3 , wherein the biosurfactant having a glycolipid structure is a succinoyl trehalose lipid.
5. The α-gel-containing composition according to claim 1 , wherein the biosurfactant is contained in an amount of 0.001% by mass or more relative to the total mass of the α-gel-containing composition.
6. The α-gel-containing composition according to claim 1 , wherein the higher alcohol includes at least one of a higher alcohol having 16 carbon atoms and a higher alcohol having 18 carbon atoms.
7. The α-gel-containing composition according to claim 1, wherein the ratio of the content of the biosurfactant to the content of the higher alcohol is greater than 0 and less than or equal to 0.500 by mass.
8. The α-gel-containing composition according to claim 1, having a pH of 5.0 or higher.
9. The α-gel-containing composition according to claim 1, further comprising at least one selected from the group consisting of an oil, a polyhydric alcohol, and a thickener.
10. The α-gel-containing composition according to claim 9 , comprising an oily agent, wherein the ratio of the content of the oily agent to the content of the higher alcohol is greater than 0 and less than or equal to 35.0 in terms of mass ratio.
11. A cosmetic or medicinal (quasi-drug) product comprising the α-gel-containing composition according to any one of claims 1 to 10.
Citation Information
Patent Citations
Aqueous gel-like composition and method for producing the same
JP2009067686A
Oily gel composition and method of preparation of emulsified composition
JP2009079030A
Cited By
Activator and skin condition improving agent
EP4631490A4
